Protyon

Protyon is dedicated to guiding clinicians toward personalized treatment and enhancing the quality of life for patients. By leveraging molecular structures to determine the most effective therapies, Protyon is at the forefront of precision medicine.

Specializing in mutations in EGFR and other key lung cancer drivers, Protyon collaborates closely with the Molecular Tumor Board at the UMCG and patient organizations throughout Europe. This collaborative approach ensures that Protyon remains deeply connected to the needs of both healthcare professionals and patients.

Located in Groningen, NL, Protyon is committed to advancing healthcare through innovative solutions. We are currently compiling more detailed information about Protyon and will be updating our platform soon with the support of the company’s management. We invite the management team at Protyon to create a customized and exclusive company showcase and product listing on our platform.